D. Gómez-Almaguer

发表

No Cytomegalovirus-related Deaths After Non-ablative Stem Cell Allografts

G. Ruiz-Argüelles, S. Ponce-de-León, D. Gómez-Almaguer, 2002, Hematology.

Current state and perspectives of stem cell therapy for stroke

D. Gómez-Almaguer, O. Cantú-Rodríguez, J. Jaime-Pérez, 2016 .

Treatment of classical Hodgkin’s lymphoma in children and adolescents

D. Gómez-Almaguer, Ó. González-Llano, Valentine Jiménez-Antolinez, 2019, Expert opinion on pharmacotherapy.

Importance of Nutrition in the Treatment of Leukemia in Children and Adolescents.

R. Barr, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2016, Archives of medical research.

Altered CSF cytokine network in amyotrophic lateral sclerosis patients: A pathway‐based statistical analysis

D. Gómez-Almaguer, J. Jaime-Pérez, S. Salazar-Marioni, 2017, Cytokine.

Sub-optimal fetal iron acquisition under a maternal environment.

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2005, Archives of medical research.

Measurements of Catheter, Venous, and Capillary Cyclosporine A Blood Are Comparable and Useful in Pediatric Hematopoietic Stem Cell Transplant Recipients

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2017, Acta Haematologica.

Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant.

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2013, Blood cells, molecules & diseases.

Iron stores in low-income pregnant Mexican women at term.

D. Gómez-Almaguer, J. Jaime-Pérez, 2002, Archives of medical research.

Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia

R. Ortíz-López, D. Gómez-Almaguer, J. Jaime-Pérez, 2013, Hematology.

Acute Leukemia Characteristics are Different Around the World: the Mexican Perspective

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2017, Clinical lymphoma, myeloma & leukemia.

Age Acts as an Adverse Independent Variable for Survival in Acute Lymphoblastic Leukemia: Data From a Cohort in Northeast Mexico

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2017, Clinical lymphoma, myeloma & leukemia.

Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2018, Clinical lymphoma, myeloma & leukemia.

Neighborhood-Poverty and Pediatric Allogeneic Hematopoietic Cell Transplantation Outcomes: A CIBMTR Analysis.

W. Wood, M. Aljurf, A. Yoshimi, 2020, Blood.

Advances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agents

D. Gómez-Almaguer, A. Gómez-De León, L. Villela-Martínez, 2020, Expert review of hematology.

Coronavirus disease-19 in Hematology. The perspective of a middle-income country

D. Gómez-Almaguer, O. Cantú-Rodríguez, J. Jaime-Pérez, 2020, Revista Medicina Universitaria.

All trans‐retinoic acid decreases early mortality in patients with promyelocytic leukemia and can be given entirely on an outpatient basis

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. L. Delgado-Lamas, 1999, American journal of hematology.

Danazol as First‐Line Therapy for Myelodysplastic Syndrome

E. Rendón-Ramírez, D. Gómez-Almaguer, J. Jaime-Pérez, 2017, Clinical lymphoma, myeloma & leukemia.

A multicenter, open-label, noncomparative screening study of enzastaurin in adult patients with non-Hodgkin lymphomas.

O. Hamid, D. Gómez-Almaguer, Neil V. Smith, 2013, Clinical lymphoma, myeloma & leukemia.

Long-Term Insulin Independence in Type 1 Diabetes Mellitus Using a Simplified Autologous Stem Cell Transplant.

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2016, The Journal of clinical endocrinology and metabolism.

Treating thrombotic thrombocytopenic purpura without plasma exchange during the COVID-19 pandemic. A case report and a brief literature review

D. Gómez-Almaguer, A. Gómez-De León, L. Tarín-Arzaga, 2021, Transfusion and Apheresis Science.

Micrometric determination of the most frequent leukemic blasts’ size

D. Gómez-Almaguer, ez José Carlos Jaime-Pérez, A. C. Esparza-Sandoval, 2014 .

Assessment of nutritional status in children with acute lymphoblastic leukemia in Northern México: A 5‐year experience

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2008, Pediatric blood & cancer.

Revisiting the complete blood count and clinical findings at diagnosis of childhood acute lymphoblastic leukemia: 10-year experience at a single center

D. Gómez-Almaguer, J. Jaime-Pérez, G. Garcia-Arellano, 2018, Hematology, transfusion and cell therapy.

Results of Treating Childhood Acute Lymphoblastic Leukemia in a Low-middle Income Country: 10 Year Experience in Northeast Mexico.

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2016, Archives of medical research.

Efficacy of mitoxantrone as frontline anthracycline during induction therapy in adults with newly diagnosed acute lymphoblastic leukemia: a single-center experience

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2015, Leukemia & lymphoma.

Random serum methotrexate determinations for assessing compliance with maintenance therapy for childhood acute lymphoblastic leukemia

D. Gómez-Almaguer, Ó. González-Llano, A. Chapa-Rodríguez, 2009, Leukemia & lymphoma.

Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia?

D. Gómez-Almaguer, J. Jaime-Pérez, P. Colunga-Pedraza, 2011, Pediatric blood & cancer.

Monthly variation in diagnosis of acute lymphoblastic leukemia and survival outcome in children and adults: 15-year trends at a single center

Marcela Hernández-Coronado, D. Gómez-Almaguer, J. Jaime-Pérez, 2021, Hematology, transfusion and cell therapy.

Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin’s lymphoma in a developing country?

G. Ruiz-Argüelles, D. Gómez-Almaguer, O. Cantú-Rodríguez, 2012, Hematology.

Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction

G. Ruiz-Argüelles, D. Gómez-Almaguer, C. Gutiérrez-Aguirre, 2014, Hematology.

Alternatives for managing patients with newly diagnosed immune thrombocytopenia: a narrative review

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2022, Expert review of hematology.

Contributions to the American Society of Hematology Meeting From Low- and Middle-Income Countries: An In-Depth Analysis and Call to Action

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2021, JCO global oncology.

RIC___Vol 72___Num 02___March-April 2020___ABRIL'20___V09.indd

D. Gómez-Almaguer, O. Cantú-Rodríguez, J. Jaime-Pérez, 2020 .

IMPACT OF HLA-DPB1 MATCHING ON CLINICAL OUTCOMES AFTER HAPLOIDENTICAL-RELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2020, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Experience with Evans syndrome in an academic referral center

D. Gómez-Almaguer, J. Jaime-Pérez, Olga Nidia López-Razo, 2015, Revista brasileira de hematologia e hemoterapia.

Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2007, Hematology.

Prescription Patterns of Daratumumab in Patients with Multiple Myeloma in Underprivileged Circumstances: A Multicenter Experience in Mexico.

J. Vela-Ojeda, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2021, Archives of medical research.

Outpatient haploidentical hematopoietic stem cell transplant using post-transplant cyclophosphamide and incidence of hemorrhagic cystitis

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2020, Hematology, transfusion and cell therapy.

Safety and Cost-Effectiveness of a Simplified Method for Lumbar Puncture in Patients with Hematologic Malignancies

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2014, Acta Haematologica.

Sexual Dimorphism in Children and Adolescents With Acute Lymphoblastic Leukemia: Influence on Incidence and Survival

D. Gómez-Almaguer, J. Jaime-Pérez, L. T. Fernández, 2019, Journal of pediatric hematology/oncology.

Audit of red blood cell transfusion in patients with acute leukemia at a tertiary care university hospital

J. Ancer-Rodríguez, D. Gómez-Almaguer, J. Jaime-Pérez, 2020, Transfusion.

Transient mixed chimerism after stem cell transplantation can induce durable molecular complete remissions in chronic myelogenous leukemia

G. Ruiz-Argüelles, D. Gómez-Almaguer, G. Ruiz-Delgado, 2006, Leukemia & lymphoma.

Combination of low-dose imatinib plus nilotinib for the treatment of chronic-phase chronic myeloid leukaemia after imatinib failure

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2016, Hematology.

The treatment of CML at an environment with limited resources

G. Ruiz-Argüelles, D. Gómez-Almaguer, O. Cantú-Rodríguez, 2016, Hematology.

Current Approaches for the Treatment of Autoimmune Hemolytic Anemia

D. Gómez-Almaguer, J. Jaime-Pérez, L. Tarín-Arzaga, 2013, Archivum Immunologiae et Therapiae Experimentalis.

Comparative analysis of iron status and other hematological parameters in preeclampsia†

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2017, Hematology.

Evans syndrome: clinical perspectives, biological insights and treatment modalities

D. Gómez-Almaguer, J. Jaime-Pérez, Lorena Salazar-Cavazos, 2018, Journal of blood medicine.

Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphoma

S. González-Díaz, D. Gómez-Almaguer, P. Colunga-Pedraza, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2009, British journal of haematology.

A clinical challenge: Treatment of acute myeloid leukemia in a Jehovah's Witness

D. Gómez-Almaguer, J. Jaime-Pérez, E. Gonzalez-Lopez, 2016, Revista brasileira de hematologia e hemoterapia.

Eltrombopag-based combination treatment for immune thrombocytopenia

D. Gómez-Almaguer, 2018, Therapeutic advances in hematology.

Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP)

D. Gómez-Almaguer, 2012, Hematology.

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias.

Manuel Solano-Genesta, D. Gómez-Almaguer, J. Jaime-Pérez, 2010, Blood.

Diagnostic concordance of pathological methods and reports of hematopathologists compared to local nonspecialized pathologists in the diagnosis of lymphoma in Mexico

D. Gómez-Almaguer, Paula Barreyro, Leonora Rojas, 2018, Hematology.

Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases

G. Ruiz-Argüelles, D. Gómez-Almaguer, Ó. González-Llano, 2000, Bone Marrow Transplantation.

Antibodies in the Treatment of Aplastic Anemia

D. Gómez-Almaguer, J. Jaime-Pérez, G. Ruiz-Arguelles, 2012, Archivum Immunologiae et Therapiae Experimentalis.

Rapid desensitization to brentuximab vedotin after severe anaphylaxis in the treatment of refractory Hodgkin’s lymphoma

D. Gómez-Almaguer, A. Gómez-De León, N. Acuña-Ortega, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease.

S. Giralt, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2013, European journal of haematology.

Convalescent plasma therapy in patients with coronavirus disease-19 – One year after: A brief review

D. Gómez-Almaguer, C. D. Galindo-Calvillo, M. Irabien-Zuñiga, 2021, Revista Medicina Universitaria.

Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial

T. Robak, T. Masszi, K. Sail, 2021, Leukemia & lymphoma.

Outpatient reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukaemia in children

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2010, British journal of haematology.

The Influence of Nutritional Status at Diagnosis of Childhood B-Cell Acute Lymphoblastic Leukemia on Survival Rates: Data from a Hispanic Cohort

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2021, Nutrition and cancer.

Mobilization kinetics of CD133+ hematoprogenitor cells for hematopoietic grafting

D. Gómez-Almaguer, J. Jaime-Pérez, O. Cantú-Rodríguez, 2009, Transfusion.

Cultural factors related to adherence to imatinib in CML: A Mexican perspective

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2015, Hematology.

The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study

D. Gómez-Almaguer, J. Jaime-Pérez, A. Rosas-Taraco, 2017, Annals of Hematology.

More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2016, Hematology.

Thrombotic thrombocytopenic purpura

D. Gómez-Almaguer, C. Tellez-Hinojosa, A. Vázquez-Mellado, 2015 .

Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus I.V. melphalan

J. Vela-Ojeda, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2007, Annals of Hematology.

Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

S. Giralt, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2008, Bone Marrow Transplantation.

Outcomes and survival predictors of Latin American older adults with acute myeloid leukemia: Data from a single center

D. Gómez-Almaguer, J. Jaime-Pérez, Eugenia M. Ramos-Dávila, 2022, Hematology, transfusion and cell therapy.

Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries

G. Ruiz-Argüelles, D. Gómez-Almaguer, A. Gómez-De León, 2021, JCO global oncology.

Acute Myeloid Leukemia in Mexico: The Specific Challenges of a Developing Country. Results From a Multicenter National Registry.

D. Gómez-Almaguer, Á. Carrillo, E. Crespo-Solis, 2019, Clinical lymphoma, myeloma & leukemia.

Molecular and cellular markers for measurable residual disease in acute lymphoblastic leukemia.

Rosana Pelayo, J. Balandrán, D. Gómez-Almaguer, 2021, Boletin medico del Hospital Infantil de Mexico.

Cord blood banking activities at a university hospital in northeast Mexico: an 8‐year experience

R. Monreal-Robles, D. Gómez-Almaguer, J. Jaime-Pérez, 2012, Transfusion.

Myelodysplasia and acute myeloid leukemia fifteen years after high-dose cyclophosphamide in a child with severe aplastic anemia

D. Gómez-Almaguer, J. Jaime-Pérez, O. Cantú-Rodríguez, 2016, Revista brasileira de hematologia e hemoterapia.

TNF-α increases in the CSF of children with acute lymphoblastic leukemia before CNS relapse.

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2017, Blood cells, molecules & diseases.

CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation

D. Gómez-Almaguer, J. Jaime-Pérez, A. Chapa-Rodríguez, 2009, Transfusion.

Oseltamivir as rescue therapy for persistent, chronic, or refractory immune thrombocytopenia: a case series and review of the literature

D. Gómez-Almaguer, A. Gómez-De León, O. Cantú-Rodríguez, 2022, Journal of Thrombosis and Thrombolysis.

Higher doses of CD34+ progenitors are associated with improved overall survival without increasing GVHD in reduced intensity conditioning allogeneic transplant recipients with clinically advanced disease

D. Gómez-Almaguer, J. Jaime-Pérez, L. Olguín‐Ramírez, 2013, Journal of clinical apheresis.

Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2007, Bone Marrow Transplantation.

Current Approaches for the Treatment of Autoimmune Hemolytic Anemia

D. Gómez-Almaguer, J. Jaime-Pérez, L. Tarín-Arzaga, 2013, Archivum Immunologiae et Therapiae Experimentalis.

A high transfusion burden following an ambulatory-allogeneic hematopoietic cell transplantation using reduced-intensity conditioning is associated with adverse outcomes.

Marcela Hernández-Coronado, D. Gómez-Almaguer, J. Jaime-Pérez, 2021, Blood cells, molecules & diseases.

Moderate hyperprolactinemia is associated with survival in patients with acute graft-versus-host disease after allogeneic stem cell transplantation

G. Ruiz-Argüelles, D. Gómez-Almaguer, C. Gutiérrez-Aguirre, 2012, Hematology.

Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non‐frozen grafts in persons with multiple sclerosis

R. Gale, M. J. Muñóz-Pérez, E. Soto-Vega, 2019, Clinical transplantation.

Hematopoietic stem cell transplantation for uncommon immune-mediated neurological disorders: A literature review.

D. Gómez-Almaguer, J. Jaime-Pérez, Eugenia M. Ramos-Dávila, 2022, Cytotherapy.

Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort

D. Galarza-Delgado, D. Gómez-Almaguer, J. Jaime-Pérez, 2021, Clinical Rheumatology.

Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease

Manuel Solano-Genesta, D. Gómez-Almaguer, J. Jaime-Pérez, 2012, Haematologica.

Matched sibling donors versus alternative donors in allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia in México

A. Olaya-Vargas, M. Pérez-García, G. Ruiz-Argüelles, 2015, Hematology.

Palliative Care for Patients With Hematologic Malignancies in a Low-Middle Income Country: Prevalence of Symptoms and the Need for Improving Quality of Attention at the End of Life

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2019, The American journal of hospice & palliative care.

Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: Report of four cases

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2013, Hematology.

Long‐term treatment results for acute megakaryoblastic leukaemia patients: a multicentre study

Marcos González, A. Órfão, G. Ruiz-Argüelles, 1992, British journal of haematology.

CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value

Manuel Solano-Genesta, I. Velasco-Ruiz, G. Ruiz-Argüelles, 2012, Hematology.

Impact of outpatient non-myeloablative haematopoietic stem cell transplantation in quality of life vs. conventional therapy

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2016, Psychology, health & medicine.

Low incidence and severity of graft‐versus‐host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced‐intensity conditioning

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2011, European journal of haematology.

Long-Term Remission and Bone Marrow Findings in Children with Severe Aplastic Anemia Immunosuppressed with High Doses ofCyclophosphamide

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2013 .

Long-Term Remission and Bone Marrow Findings in Children with Severe Aplastic Anemia Immunosuppressed with High Doses of

D. Gómez-Almaguer, Ó. González-Llano, O. Cantú-Rodríguez, 2013 .

High‐dose cyclophosphamide in the treatment of severe aplastic anemia in children

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2001, American journal of hematology.

Lactate dehydrogenase as a hematopoietic stem cell mobilization biomarker in autologous transplantation

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2022, Hematology, transfusion and cell therapy.

Increased blood transfusion after outpatient autologous transplantation with reduced intensity conditioning for hematological malignancies predicts worse outcomes

J. Ancer-Rodríguez, Marcela Hernández-Coronado, D. Gómez-Almaguer, 2021, Clinical transplantation.

Hematologist Intervention in Disseminated Intravascular Coagulation - Has Something Changed in 2018?

D. Gómez-Almaguer, José Miguel Yáñez-Reyes, Emmanuel Bugarín-Estrada, 2019, Revista Medicina Universitaria.

An audit of platelet transfusion indications in acute leukaemia patients: six-year experience at an Academic Centre.

D. Gómez-Almaguer, J. Jaime-Pérez, D. M. Alvarado-Navarro, 2020, Blood transfusion = Trasfusione del sangue.

Consistency and reproducibility in the platelet‐rich plasma preparation method: Mexican experience

J. Ocampo-Candiani, L. Villarreal-Martínez, D. Gómez-Almaguer, 2019, International journal of laboratory hematology.

Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience.

G. Ruiz-Argüelles, D. Gómez-Almaguer, B. López-Martínez, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pernicious anaemia can be treated effectively with a single high dose of cobalamin

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2020, British journal of haematology.

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Mohammad Sohel Rahman, Henrik Nielsen, M. Shankar-Hari, 2021, BMC Infectious Diseases.

Danazol as first-line therapy for aplastic anemia

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2011, Annals of Hematology.

Sweet syndrome presenting late after non Hodgkin's lymphoma and dermatomyositis

D. Gómez-Almaguer, J. Jaime-Pérez, C. Mendoza-Rodríguez, 2014 .

Antibodies in the Treatment of Aplastic Anemia

D. Gómez-Almaguer, J. Jaime-Pérez, G. Ruiz-Arguelles, 2012, Archivum Immunologiae et Therapiae Experimentalis.

Hematopoietic stem cell transplantation activity in Mexico during the COVID19 pandemic: on the way to recovery

Manuel Solano-Genesta, A. Olaya-Vargas, M. Pérez-García, 2022, Hematology.

Outpatient transplantation in the COVID-19 era: a single-center Latin American experience

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2021, Bone Marrow Transplantation.

Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2010, Annals of Hematology.

Making Allogeneic Bone Marrow Transplantation Available to Patients in Developing Countries: The Mexican Experience

G. Ruiz-Argüelles, D. Gómez-Almaguer, 2008 .

Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine‐based conditioning regimen: The Mexican experience

J. Vela-Ojeda, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2006 .

Haematopoietic stem cell transplantation to treat aplastic anaemia

D. Gómez-Almaguer, J. Jaime-Pérez, G. Ruiz-Arguelles, 2005, Expert opinion on biological therapy.

Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.

J. Vela-Ojeda, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2005, American journal of hematology.

Outpatient allogeneic hematopoietic stem-cell transplantation: a review

D. Gómez-Almaguer, O. Cantú-Rodríguez, C. Gutiérrez-Aguirre, 2022, Therapeutic advances in hematology.

Assessing the efficacy of an ambulatory peripheral blood hematopoietic stem cell transplant program using reduced intensity conditioning in a low-middle-income country

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2018, Bone Marrow Transplantation.

Cyclosporine A for the Prevention of Ocular Graft versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is Safe and Feasible

D. Gómez-Almaguer, J. Jaime-Pérez, David Mauricio Martínez-Garza, 2019, Acta Haematologica.

Dimethyl Sulfoxide-Induced Toxicity in Cord Blood Stem Cell Transplantation: Report of Three Cases and Review of the Literature

David Gómez-Almaguer, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles, 2009, Acta Haematologica.

Acute maternal cytomegalovirus infection is associated with significantly decreased numbers of CD34+ cells in umbilical cord blood.

R. Monreal-Robles, D. Gómez-Almaguer, J. Jaime-Pérez, 2012, Blood cells, molecules & diseases.

P838: PEGCETACOPLAN RAPIDLY STABILIZES COMPLEMENT INHIBITOR NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA EXPERIENCING HEMOLYSIS WITH ACUTE HEMOGLOBIN DECREASES; PRINCE TRIAL POST HOC ANALYSIS

D. Gómez-Almaguer, R. Wong, R. Horneff, 2022, HemaSphere.

Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria

D. Gómez-Almaguer, G. Ruiz-Delgado, E. Vázquez-Garza, 2009, Hematology.

No clinically relevant differences between capillary and venous blood cell counts in adult haematological patients using a nonautomated lancet

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2015, International journal of laboratory hematology.

Platelet refractoriness to classical agonists in a child with essential thrombocythemia

D. Gómez-Almaguer, J. Jaime-Pérez, 2005, Platelets.

Platelet aggregation in children with acute lymphoblastic leukemia during induction of remission therapy.

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2004, Archives of medical research.

Prevalence and Clinical Significance of FLT3 Mutation Status in Acute Myeloid Leukemia Patients: A Multicenter Study.

R. Ortíz-López, D. Gómez-Almaguer, J. Jaime-Pérez, 2016, Archives of medical research.

Assessment of immune reconstitution status in recipients of a successful hematopoietic stem cell transplant from peripheral blood after reduced intensity conditioning.

D. Gómez-Almaguer, J. Jaime-Pérez, R. Salazar-Riojas, 2016, Blood cells, molecules & diseases.

Splitting the Total Dose of Cyclophosphamide in Two Blocks Apart during the Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Results in Diminished Cardiotoxicity: Experience in 1,000 Patients.

G. Ruiz-Argüelles, D. Gómez-Almaguer, G. Ruiz-Delgado, 2021, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Modifications to the Classical Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

G. Ruiz-Argüelles, D. Gómez-Almaguer, G. Ruiz-Delgado, 2017 .

Results of an outpatient‐based stem cell allotransplant program using nonmyeloablative conditioning regimens

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2001, American journal of hematology.

Do immunoglobulin G and immunoglobulin E anti-l-asparaginase antibodies have distinct implications in children with acute lymphoblastic leukemia? A cross-sectional study

S. González-Díaz, D. Gómez-Almaguer, J. Jaime-Pérez, 2017, Revista brasileira de hematologia e hemoterapia.

Iron deficiency anemia referral to the hematologist. Real-world data from Mexico: the need for targeted teaching in primary care

D. Gómez-Almaguer, J. Jaime-Pérez, P. Colunga-Pedraza, 2018, Hematology.

Platelet Survival in Hematology Patients Assessed by the Corrected Count Increment and Other Formulas

D. Gómez-Almaguer, J. Jaime-Pérez, L. T. Fernández, 2018, American journal of clinical pathology.

Acute myeloid leukemia: challenges for diagnosis and treatment in Latin America

E. Rego, D. Gómez-Almaguer, A. Gómez-De León, 2023, Hematology.

Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults.

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2014, Blood.

newly diagnosed immune thrombocytopenia in adults Eltrombopag and high-dose dexamethasone as frontline treatment of

G. Ruiz-Argüelles, D. Gómez-Almaguer, O. Cantú-Rodríguez, 2014 .

Adult patients with immune thrombocytopenic purpura. New expectations

D. Gómez-Almaguer, 2014 .

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Francisco Cervantes, Ryuzo Ohno, Richard E. Clark, 2013, Blood.

Impact of Obesity on Lumbar Puncture Outcomes in Adults with Acute Lymphoblastic Leukemia and Lymphoma: Experience at an Academic Reference Center

D. Gómez-Almaguer, J. Jaime-Pérez, Guillermo Sotomayor-Duque, 2019, International journal of hematology-oncology and stem cell research.

Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia (AML) is feasible: a multicentre study

D. Gómez-Almaguer, D. Aleman-Hoey, A. Marín‐López, 1995, European journal of haematology.

More about Imatinib and Nilotinib Combination Therapy in Chronic Myeloid Leukemia

D. Gómez-Almaguer, O. Cantú-Rodríguez, L. Tarín-Arzaga, 2012, Acta Haematologica.

Insights into the management of chronic myeloid leukemia in resource-poor settings: a Mexican perspective

David Gómez-Almaguer, D. Gómez-Almaguer, Andrés Gomez-de-León, 2017, Expert review of hematology.

Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2018, Hematology.

Assessing the performance of a plateletpheresis unit at a tertiary‐care academic medical center in Mexico: A 6‐year experience

J. Ancer-Rodríguez, D. Gómez-Almaguer, J. Jaime-Pérez, 2021, Journal of clinical apheresis.

Successful father‐to‐son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced‐intensity conditioning regimen

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2006, European Journal of Haematology.

Outpatient allografting using non-myeloablative conditioning: the Mexican experience

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2007, Bone Marrow Transplantation.

Extramedullary Leukemic Relapses Following Hematopoietic Stem Cell Transplantation with Nonmyeloablative Conditioning

J. Vela-Ojeda, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2005, International Journal of Hematology.

Breaking dogmata to help patients: non-myeloablative haematopoietic stem cell transplantation

G. Ruiz-Argüelles, D. Gómez-Almaguer, 2004, Expert opinion on biological therapy.

Allogeneic Hematopoietic Stem Cell Transplantation with Non-Myeloablative Conditioning in Patients with Acute Myelogenous Leukemia Eligible for Conventional Allografting: A Prospective Study

J. Vela-Ojeda, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2004, Leukemia & lymphoma.

Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas

R. Gale, L. Feldman, G. Ruiz-Argüelles, 2018, Bone Marrow Transplantation.

Pregnancy-associated aplastic anemia: a case-based review

D. Gómez-Almaguer, J. Jaime-Pérez, Mariana González-Treviño, 2021, Expert review of hematology.

Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3–CD19 depletion

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2014, Hematology.

Evaluation of volume and total nucleated cell count as cord blood selection parameters: a receiver operating characteristic curve modeling approach.

R. Monreal-Robles, D. Gómez-Almaguer, J. Jaime-Pérez, 2011, American journal of clinical pathology.

Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experience

D. Gómez-Almaguer, G. Ruiz-Delgado, Alejandro Schcolnik-Cabrera, 2015, Hematology.

Allogeneic peripheral blood stem cell transplantation using reduced‐intensity conditioning in an outpatient setting in ABO‐incompatible patients: are survival and graft‐versus‐host disease different?

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2014, Transfusion.

Mobilization kinetics of CD34+ hematopoietic stem cells stimulated by G-CSF and cyclophosphamide in patients with multiple sclerosis who receive an autotransplant.

D. Gómez-Almaguer, J. Jaime-Pérez, R. Salazar-Riojas, 2020, Cytotherapy.

Effective collection of peripheral blood stem cells in children weighing 20 kilogram or less in a single large‐volume apheresis procedure

D. Gómez-Almaguer, Ó. González-Llano, A. Gómez-De León, 2015, Journal of clinical apheresis.

Haploidentical Bone Marrow Transplantation in 2015 and Beyond

G. Ruiz-Argüelles, D. Gómez-Almaguer, Ó. González-Llano, 2015, Current Oncology Reports.

Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico.

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2015, The oncologist.

Severe acute respiratory syndrome coronavirus 2 vaccines: The good, the bad, and the ugly

D. Gómez-Almaguer, M. Salinas-Carmona, Katia N. Estrada-Medrano, 2021, Revista Medicina Universitaria.

Results of a completely outpatient autologous stem cell transplant program for lymphoma patients receiving reduced-intensity conditioning

Marcela Hernández-Coronado, D. Gómez-Almaguer, J. Jaime-Pérez, 2021, Leukemia & lymphoma.

A single apheresis procedure in the donor may be enough to complete an allograft using the "Mexican method" of non-ablative allografting.

G. Ruiz-Argüelles, D. Gómez-Almaguer, G. Ruiz-Delgado, 2009, Blood transfusion = Trasfusione del sangue.

Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia.

G. Ruiz-Argüelles, D. Gómez-Almaguer, B. López-Martínez, 2002, Haematologica.

[Acute leukemia in Jehovah's Witnesses: difficulties in its management].

G. Ruiz-Argüelles, D. Gómez-Almaguer, A. Lozano de la Vega, 1990, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Second allogeneic peripheral blood stem cell transplants with reduced-intensity conditioning.

G. Ruiz-Argüelles, D. Gómez-Almaguer, O. Cantú-Rodríguez, 2006, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

The simplification of the SCT procedures in developing countries has resulted in cost-lowering and availability to more patients

D. Gómez-Almaguer, 2002, International journal of hematology.

Outdated dogma? Busulfan, seizure prophylaxis, and stem cell allografting

D. Steensma, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2012, American journal of hematology.

The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter study

J. Vela-Ojeda, S. Giralt, D. Gómez-Almaguer, 2005, Bone Marrow Transplantation.

Allogeneic Hematopoietic Stem Cell Transplantation with Nonmyeloablative Conditioning in Patients with Myeloid Leukemias: Results of a Prospective Study of the Latin American Cooperative Onco Hematology Group (LACOHG).

J. Vela-Ojeda, D. Gómez-Almaguer, O. Cantú-Rodríguez, 2004 .

The Mexican Approach to Conduct Nonmyeloablative Stem Cell Transplantation Should Not Be Overlooked

G. Ruiz-Argüelles, D. Gómez-Almaguer, 2003, International journal of hematology.

Features of the Engraftment of Allogeneic Hematopoietic Stem Cells Using Reduced-Intensity Conditioning Regimens

G. Ruiz-Argüelles, D. Gómez-Almaguer, B. López-Martínez, 2001, Leukemia & lymphoma.

Moral distress: its manifestations in healthy donors during peripheral blood hematopoietic stem cell harvesting.

D. Gómez-Almaguer, O. Cantú-Rodríguez, J. Jaime-Pérez, 2021, Transplantation and cellular therapy.

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and Feasible.

D. Gómez-Almaguer, A. Gómez-De León, O. Cantú-Rodríguez, 2021, Transplantation and cellular therapy.

Outpatient low toxic regimen with bortezomib in relapsed/refractory acute lymphoblastic leukemia in pediatrics and AYA patients: Single‐center Mexican experience

D. Gómez-Almaguer, Ó. González-Llano, Valentine Jiménez-Antolinez, 2020, Pediatric blood & cancer.

G. Ruiz-Argüelles, D. Gómez-Almaguer, G. Ruiz-Delgado, 2015, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Chemotherapy Alone or HSCT After Reduced-Intensity Conditioning for Patients with Malignant Hematologic Diseases Are Not Associated to Metabolic Syndrome: A Cross-Sectional Observational Study

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2014, Nutrition and cancer.

Long-term results of placental blood allografting using reduced-intensity conditioning: multicenter experience in a developing country

G. Ruiz-Argüelles, D. Gómez-Almaguer, Ó. González-Llano, 2011, Hematology.

Reduced-intensity allografting in childhood acute lymphoblastic leukemia.

D. Gómez-Almaguer, G. Ruiz-Delgado, L. Rodríguez-Romo, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2010, Annals of Hematology.

Nephrotic syndrome after non‐myeloablative stem cell transplantation

D. Gómez-Almaguer, Guillermo J. Ruiz‐Arguelles, 2006, British journal of haematology.

Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide in children and adolescents with hematological malignancies

G. Ruiz-Argüelles, D. Gómez-Almaguer, Ó. González-Llano, 2016, Pediatric blood & cancer.

Bone marrow transplantation in a child with hemophagocytic lymphohistiocytosis using a less toxic conditioning regimen.

D. Gómez-Almaguer, Ó. González-Llano, J. Herrera-Garza, 1999, Archives of medical research.

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

A. Gennery, M. Aljurf, B. George, 2019, Blood advances.

Hospitalization rate and costs in acute lymphoblastic leukemia of childhood in a low‐income group: Financial impact in Northeast Mexico

D. Gómez-Almaguer, J. Jaime-Pérez, L. T. Fernández, 2017, Pediatric blood & cancer.

Identification of Differentially Expressed Genes Associated with Prognosis of B Acute Lymphoblastic Leukemia

A. Hidalgo-Miranda, M. Martinez-Fierro, Á. Lugo‐Trampe, 2015, Disease markers.

Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study

M. Roa, C. Sossa, G. Ruiz-Argüelles, 2020, Leukemia & lymphoma.

The paradox of haematopoietic cell transplant in Latin America

R. Gale, B. Simões, D. Gómez-Almaguer, 2021, Bone Marrow Transplantation.

Hyperglycemia related to high-dose glucocorticoid use in noncritically ill patients

R. Rodríguez‐Gutiérrez, D. Gómez-Almaguer, H. Tamez-Pérez, 2013, Diabetology & Metabolic Syndrome.

Vasculitis in hairy cell leukemia: Rapid response to interferon alpha

D. Gómez-Almaguer, J. Herrera-Garza, B. Garcia‐Guajardo, 1989, American journal of hematology.

Characteristics and Clinical Evolution of Patients with Acute Myeloblastic Leukemia in Northeast Mexico: An Eight-Year Experience at a University Hospital

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2014, Acta Haematologica.

Acute Promyelocytic Leukemia: A Long-Term Retrospective Study in Mexico

E. Cervera, D. Gómez-Almaguer, J. A. de la Peña, 2021, Journal of hematology.

The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL)

R. Ribeiro, C. Niemeyer, M. Sanz, 2012, Hematology.

High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimen

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 1999, Bone Marrow Transplantation.

Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries

J. H. Lee, Kihyun Kim, W. Chng, 2019, Annals of Hematology.

Observational study of multiple myeloma in Latin America

N. Hamerschlak, G. Conte, Â. Maiolino, 2016, Annals of Hematology.

Latin America: the next region for haematopoietic transplant progress

Y. Kodera, A. Gratwohl, H. Baldomero, 2017, Bone Marrow Transplantation.

Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial.

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2014, Cytotherapy.

Efficacy and Safety of Pegcetacoplan Treatment in Complement-Inhibitor Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Phase 3 Prince Study

T. Ajayi, R. Wong, D. Gómez-Almaguer, 2021, Blood.

Hairy cell leukemia, an uncommon B-cell lymphoid neoplasia

D. Gómez-Almaguer, M. A. Garza-Ledezma, E. Gonzalez-Lopez, 2016 .

Outcomes of second hematopoietic stem cell transplantation using reduced‐intensity conditioning in an outpatient setting

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2020, Hematological oncology.

The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants

J. García, J. Vela-Ojeda, L. Feldman, 2017, Bone Marrow Transplantation.

Donor Lymphocyte Infusion from G-CSF-Primed, Unmanipulated Whole Blood Is Safe and Improves Chimerism in HLA-Matched and Haploidentical Transplantation

D. Gómez-Almaguer, O. Cantú-Rodríguez, P. Colunga-Pedraza, 2018, Biology of Blood and Marrow Transplantation.

Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19

Marcela Hernández-Coronado, D. Gómez-Almaguer, J. Jaime-Pérez, 2021, Hematology, transfusion and cell therapy.

Acute lymphoblastic leukemia of childhood presenting as aplastic anemia: report of two cases

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2012, Revista brasileira de hematologia e hemoterapia.

Pleural extramedullary hematopoiesis due to severe pernicious anemia

D. Gómez-Almaguer, S. Castillo-Torres, A. Atilano-Díaz, 2019, Medicina Clínica (English Edition).

Hematopoyesis extramedular pleural secundaria a anemia perniciosa grave

D. Gómez-Almaguer, S. Castillo-Torres, A. Atilano-Díaz, 2019, Medicina Clínica.

Acyclovir in the treatment of aplastic anemia

D. Gómez-Almaguer, J. Marfil‐Rivera, Alex Kudish‐Wersh, 1988, American journal of hematology.

The effect of intra‐articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis

F. Vilchez-Cavazos, C. Acosta-Olivo, L. Villarreal-Martínez, 2017, International journal of rheumatic diseases.

Cytochrome P450 inhibition to decrease dosage and costs of venetoclax and ibrutinib: A proof‐of‐concept case study

D. Gómez-Almaguer, P. Colunga-Pedraza, F. De la Garza-Salazar, 2022, British journal of clinical pharmacology.

Survival Rates of Adults With Acute Lymphoblastic Leukemia in a Low‐Income Population: A Decade of Experience at a Single Institution in Mexico

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2017, Clinical lymphoma, myeloma & leukemia.

Vinblastine as a bridge to 7 + 3 in acute myeloid leukaemia

D. Gómez-Almaguer, A. Gómez-De León, P. Colunga-Pedraza, 2023, Annals of Hematology.

Molecular characterization of chronic myeloproliferative neoplasias in México

R. Ortíz-López, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2009, Hematology.

Increased bacterial infections after transfusion of leukoreduced non-irradiated blood products in recipients of allogeneic stem cell transplants after reduced-intensity conditioning.

D. Gómez-Almaguer, J. Jaime-Pérez, R. Salazar-Riojas, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of hairy cell leukemia: long-term results in a developing country

G. Ruiz-Argüelles, D. Gómez-Almaguer, G. Ruiz-Delgado, 2012, Hematology.

Nutritional status and socio‐economic conditions as prognostic factors in the outcome of therapy in childhood acute lymphoblastic leukemia

G. Ruiz-Argüelles, D. Gómez-Almaguer, S. Ponce-de-León, 1998, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Use of complementary and alternative medicine by patients with hematological diseases experience at a university hospital in northeast Mexico

D. Gómez-Almaguer, J. Jaime-Pérez, A. Chapa-Rodríguez, 2012, Revista brasileira de hematologia e hemoterapia.

Immunoreactivity of common red blood cell antigens in cytoskeleton-free red blood cell microvesicles.

D. Gómez-Almaguer, J. Jaime-Pérez, 2000, Archives of medical research.

Hairy cell leukemia is infrequent in México and has a geographic distribution

J. Pizzuto, G. Ruiz-Argüelles, D. Gómez-Almaguer, 1996, American journal of hematology.

Treatment of diffuse large B‐cell lymphoma with and without anthracyclines and rituximab in patients older than 60 years: 10‐year results at a Latin American center

D. Gómez-Almaguer, J. Jaime-Pérez, L. T. Fernández, 2019, Hematological oncology.

Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2019, British journal of haematology.

Treatment of Ph-Negative Acute Lymphoblastic Leukemia in Adolescents and Young Adults with an Affordable Outpatient Pediatric Regimen.

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2022, Clinical lymphoma, myeloma & leukemia.

[Primary immune thrombocytopenia in adults in Mexico: national characteristics and the relation to international literature].

D. Gómez-Almaguer, J. García-Chávez, G. Gutiérrez-Espíndola, 2014, Gaceta medica de Mexico.

Clinical presentation in thrombotic thrombocytopenic purpura: Real‐world data from two Mexican institutions

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2018, Journal of clinical apheresis.

Diagnoses, Outcomes, and Chronicity Predictors of Patients with Secondary Immune Thrombocytopenia: Ten-Year Data from a Hematology Referral Center.

D. Gómez-Almaguer, J. Jaime-Pérez, Eugenia M. Ramos-Dávila, 2020, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Relationship Between Gestational Iron Deficiency and Iron Deficiency in the Newborn

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2000, Hematology.

Contributions of a regional approach to document hematologic disease in Mexico: a 10-year experience in an open population

D. Gómez-Almaguer, J. Jaime-Pérez, O. Cantú-Rodríguez, 2018, Hematology.

Blood transfusion in children at a university hospital in a middle-income country: The need to reinforce adherence to current guidelines.

L. Villarreal-Martínez, A. Meléndez-Aguirre, D. Gómez-Almaguer, 2020, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center

D. Gómez-Almaguer, J. Jaime-Pérez, Eugenia M. Ramos-Dávila, 2020, Annals of Hematology.

Romiplostim, Low-Dose Rituximab and High-Dose Dexamethasone Combination in Newly Diagnosed Immune Thrombocytopenia: Another "Total Therapy" Pilot Study

D. Gómez-Almaguer, A. Gómez-De León, P. Colunga-Pedraza, 2021, Blood.

A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL).

L. Villela, M. Cabrera, J. Castillo, 2020, Clinical lymphoma, myeloma & leukemia.

Alemtuzumab and Rituximab in the treatment of refractory autoimmune Cytopenias.

Manuel Solano-Genesta, D. Gómez-Almaguer, O. Cantú-Rodríguez, 2009 .

Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.

D. Gómez-Almaguer, J. Jaime-Pérez, A. Vázquez-Mellado de Larracoechea, 2015, Archives of medical research.

PB1762: PONATINIB VERSUS IMATINIB WITH REDUCED-INTENSITY CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PHALLCON STUDY

H. Dombret, M. Vignetti, E. Jabbour, 2021, HemaSphere.

Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.

A. Ganser, S. Schrier, F. Lo‐Coco, 2013, Blood.

Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry

Carmina Alejandra Córdova-Ramírez, A. Milan, D. Gómez-Almaguer, 2020, Blood.

Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia.

A. Hidalgo-Miranda, R. Ortíz-López, A. Rojas-Martínez, 2015, Cancer biomarkers : section A of Disease markers.

Effectiveness of dasatinib in relapsed CNS, Ph+ ALL that is refractory to radiochemotherapy plus imatinib: a case report.

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2011, Clinical advances in hematology & oncology : H&O.

[3 cases of bone marrow necrosis in acute leukemia].

D. Gómez-Almaguer, J. Herrera-Garza, R. E. De León-Cantú, 1997, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Real‐world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: Results at a single center in Latin America

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2017, Pediatric blood & cancer.

Gilbert's syndrome disclosed during the treatment of hematological malignancies

G. Ruiz-Argüelles, D. Gómez-Almaguer, G. Ruiz-Delgado, 2005, Hematology.

Publications of bone marrow transplants in Latin America. A report of the Latin American Group of Bone Marrow Transplantation

L. Bouzas, D. Gómez-Almaguer, A. Seber, 2015, Bone Marrow Transplantation.

Is There Still a Role for Low-Dose All-Transretinoic Acid in the Treatment of Acute Promyelocytic Leukemia in the Arsenic Trioxide Era?

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2015, Clinical lymphoma, myeloma & leukemia.

on APL countries through networking, results of the International Consortium Improving acute promyelocytic leukemia (APL) outcome in developing

A. Ganser, S. Schrier, F. Lo‐Coco, 2013 .

Evaluation of hemoglobin performance in the assessment of iron stores in feto-maternal pairs in a high-risk population: receiver operating characteristic curve analysis

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2015, Revista brasileira de hematologia e hemoterapia.

Treatment of autoimmune hemolytic anemia: real world data from a reference center in Mexico

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2019, Blood research.

Bone marrow architecture reconstitution after hematopoietic grafting: A cross-sectional study

D. Gómez-Almaguer, J. Jaime-Pérez, L. T. Fernández, 2017 .

Early changes in IL‐21, IL‐22, CCL2, and CCL4 serum cytokines after outpatient autologous transplantation for multiple sclerosis: A proof of concept study

D. Gómez-Almaguer, J. Jaime-Pérez, R. Salazar-Riojas, 2020, Clinical transplantation.

Autologous hematopoietic cell transplantation in acute myelogenous leukemia

D. Gómez-Almaguer, C. H. Gutiérrez-Aguirre, al Xitlaly J González-Leal, 2014 .

Commentary on: First‐in‐patient study of hetrombopag in patients with chronic idiopathic thrombocytopenic purpura

D. Gómez-Almaguer, 2020, Journal of thrombosis and haemostasis : JTH.

Building a hematopoietic cell transplantation outcomes registry in Mexico

L. M. Valero-Saldaña, B. Acosta-Maldonado, E. León-Rodríguez, 2020, Bone Marrow Transplantation.

Reduced‐dose plerixafor as a mobilization strategy in autologous hematopoietic cell transplantation: a proof of concept study

D. Gómez-Almaguer, J. Jaime-Pérez, D. M. Alvarado-Navarro, 2019, Transfusion.

Venetoclax-based combinations for acute myeloid leukemia: optimizing their use in Latin-America

R. Ovilla-Martínez, D. Gómez-Almaguer, A. Gómez-De León, 2022, Hematology.

Improving the Treatment Outcome of Acute Promyelocytic Leukemia in Developing Countries through International Cooperative Network. Report On the International Consortium On Acute Promyelocytic Leukemia Study Group.

F. Lo‐Coco, R. Ribeiro, C. Niemeyer, 2009 .

Hematopoietic stem cell transplants for persons with multiple sclerosis: Is this the best therapeutic option?

G. Ruiz-Argüelles, D. Gómez-Almaguer, G. Ruiz-Argüelles, 2017 .

The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2021, Frontiers in Neurology.

Economic Challenges in Hematopoietic Cell Transplantation: How Will New and Established Programs Face the Growing Costs?

J. Szer, D. Weisdorf, A. Srivastava, 2017, Biology of Blood and Marrow Transplantation.

High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma

D. Gómez-Almaguer, G. Ruiz-Delgado, I. Murrieta-Alvarez, 2022, Hematology.

PERSPECTIVES IN DIAGNOSIS AND THERAPEUTICS IN HEMATOLOGY.

G. Ruiz-Argüelles, D. Gómez-Almaguer, 2021, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Successful second outpatient autologous hematopoietic cell transplant for relapsed POEMS syndrome in a patient with coexisting HIV, HBV and syphilis infections during the COVID-19 pandemic.

J. Ocampo-Candiani, Marcela Hernández-Coronado, D. Gómez-Almaguer, 2021, Transplant immunology.

Lessons Learned Treating Patients with Multiple Myeloma in Resource-Constrained Settings

G. Ruiz-Argüelles, D. Gómez-Almaguer, D. Gómez‐Almaguer, 2021, Current Hematologic Malignancy Reports.

Efficacy of three filgrastim‐intended copies for hematopoietic stem cell mobilization in healthy adult and pediatric donors in Mexico

D. Gómez-Almaguer, Ó. González-Llano, A. Gómez-De León, 2019, Journal of clinical apheresis.

Intrathecal delivery of bone marrow stem cells in ALS: A preliminary report

D. Gómez-Almaguer, J. Jaime-Pérez, H. R. Martinez, 2017 .

Childhood T-cell acute lymphoblastic leukemia in a single Latin American center: impact of improved treatment scheme and support therapy on survival

D. Gómez-Almaguer, J. Jaime-Pérez, José Antonio Hernández-de los Santos, 2019, Hematology, transfusion and cell therapy.

Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia

D. Gómez-Almaguer, J. Jaime-Pérez, L. T. Fernández, 2018, International journal of laboratory hematology.

J. Ancer-Rodríguez, D. Gómez-Almaguer, J. Jaime-Pérez, 2023, Clinical transplantation.

Chemotherapy alone may be an efficient alternative in the treatment of early stage Hodgkin's disease if optimal radiotherapy is not available.

G. Ruiz-Argüelles, D. Gómez-Almaguer, M. G. Apreza-Molina, 1997, Leukemia & lymphoma.

Skin Manifestations Associated with Chemotherapy in Children with Hematologic Malignancies

J. Ocampo-Candiani, D. Gómez-Almaguer, Ó. González-Llano, 2012, Pediatric dermatology.

Plateletpheresis efficiency and mathematical correction of software‐derived platelet yield prediction: A linear regression and ROC modeling approach

D. Gómez-Almaguer, J. Jaime-Pérez, R. Salazar-Riojas, 2017, Journal of clinical apheresis.

Orbital myeloid sarcoma treated with low-dose venetoclax and a potent cytochrome P450 inhibitor

D. Gómez-Almaguer, P. Colunga-Pedraza, F. De la Garza-Salazar, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Insights on chronic immune thrombocytopenia pathogenesis: A bench to bedside update.

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2021, Blood reviews.

Impact of the affordability of novel agents in patients with multiple myeloma: Real‐world data of current clinical practice in Mexico

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2018, Cancer.

Concordant acute myeloblastic leukemia in identical twins treated with allogeneic transplantation from a younger HLA-identical sibling following a single apheresis procedure

Marcela Cantú-Moreno, D. Gómez-Almaguer, Ó. González-Llano, 2020, International journal of hematologic oncology.

High‐dose cyclophosphamide in the treatment of severe aplastic anemia in children

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2001, American journal of hematology.

Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant

D. Gómez-Almaguer, M. A. Reyes-López, O. Martínez-González, 2021, Revista Medicina Universitaria.

Moral Distress, Anxiety, and Others Physical Symptoms Related to Hematopoietic Stem Cell Donation

G. Ruiz-Argüelles, D. Gómez-Almaguer, Geraldina Guerrero-González, 2019, Blood.

Incidence, severity, and outcome of adverse events to chemotherapeutic drugs used in hematological malignancies: Data from a reference center

D. Gómez-Almaguer, J. Jaime-Pérez, G. Garcia-Arellano, 2019, Revista Medicina Universitaria.

Pediatric hematopoietic SCT in Mexico: recent activity and main problems

D. Gómez-Almaguer, Ó. González-Llano, G. Ruiz-Delgado, 2011, Bone Marrow Transplantation.

High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gamboa-Alonso, 2017, Revista brasileira de hematologia e hemoterapia.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

J. Radich, H. Kantarjian, D. B. Yehuda, 2013, Blood.

Long-Term Efficacy of High-Dose Imatinib in Hispanic Patients Without Access to Second-Generation Tyrosine Kinase Inhibitors Treated in LATAM Centers.

D. Gómez-Almaguer, J. Jaime-Pérez, E. Dorsey-Treviño, 2023, Clinical lymphoma, myeloma & leukemia.

The complex nature of the prothrombotic state in acute lymphoblastic leukemia of childhood.

D. Gómez-Almaguer, J. Jaime-Pérez, 2003, Haematologica.

Flow cytometry data analysis of CD34+/CD133+ stem cells in bone marrow and peripheral blood and T, B, and NK cells after hematopoietic grafting

D. Gómez-Almaguer, J. Jaime-Pérez, E. Vázquez-Garza, 2016, Data in brief.

Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia?

D. Gómez-Almaguer, J. Jaime-Pérez, P. Colunga-Pedraza, 2011, Pediatric blood & cancer.

Detecting residual bcr-abl transcripts in chronic myeloid leukaemia patients using coupled reverse transcriptase-polymerase chain reaction with rTth DNA polymerase.

H. Barrera-Saldana, D. Gómez-Almaguer, J. M. Viader-Salvadó, 1998, Clinical and laboratory haematology.

Cyber technologies, electronic health records, physicians and patients

D. Gómez-Almaguer, C. Olivo, 2017 .

[Dengue during pregnancy, less incidence of thrombocytopenia than in general population].

D. Gómez-Almaguer, David Gómez-Almaguer, Cesar Homero Gutiérrez-Aguirre, 2019, Revista de salud publica.

First report of PhALLCON: A phase 3 study comparing ponatinib (pon) vs imatinib (im) in newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).

H. Kantarjian, E. Jabbour, I. Aldoss, 2023, Journal of Clinical Oncology.

Phase 3 PhALLCON study: Ponatinib (PON) versus imatinib (IM) with reduced-intensity chemotherapy (CT) in patients (pts) with newly diagnosed Philadelphia chromosome–positive (Ph+) ALL.

M. Vignetti, H. Kantarjian, G. Martinelli, 2019, Journal of Clinical Oncology.

Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experience

D. Gómez-Almaguer, G. Ruiz-Delgado, Alejandro Schcolnik-Cabrera, 2015, Hematology.

Graft-versus-host disease after an outpatient peripheral blood hematopoietic cell transplant using reduced-intensity conditioning: a single-center LATAM experience.

D. Gómez-Almaguer, J. Jaime-Pérez, A. Gómez-De León, 2024, Expert review of hematology.

Editorial: 50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation

N. Hamerschlak, D. Gómez-Almaguer, D. McLornan, 2023, Frontiers in oncology.

Role of bone marrow examination in staging Hodgkin's disease: experience in México.

G. Ruiz-Argüelles, D. Gómez-Almaguer, B. López-Martínez, 2002, Clinical and laboratory haematology.

[National guidelines of diagnosis and treatment of the non-Hodgkin lymphoma].

L. Villela, A. Avilés-Salas, M. Candelaria, 2013, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

H. Kantarjian, I. Aldoss, C. Gambacorti-Passerini, 2024, JAMA.

Low Dose Rituximab Plus High Dose Dexamethasone As First-Line Treatment for Autoimmune Hemolytic Anemia

D. Gómez-Almaguer, Michelle Morcos-Sandino, A. C. Rodríguez-Zúñiga, 2020 .

Comparison of CD4+/CD8+ Lymphocytic Subpopulations Pre- and Post-Antituberculosis Treatment in Patients with Diabetes and Tuberculosis

D. Gómez-Almaguer, A. Arce-Mendoza, P. Colunga-Pedraza, 2023, Pathogens.

Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant.

D. Gómez-Almaguer, J. Jaime-Pérez, J. Herrera-Garza, 2013, Blood cells, molecules & diseases.